Cargando…
Regenerative Medicine of the Bile Duct: Beyond the Myth
Cholangiopathies are rare diseases of the bile duct with high mortality rates. The current treatment for cholangiopathies is liver transplantation, but there are significant obstacles including a shortage of donors and a high risk of complications. Currently, there is only one available medicine on...
Autores principales: | Buisson, Elina Maria, Jeong, Jaemin, Kim, Han Joon, Choi, Dongho |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Korean Society for Stem Cell Research
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6657949/ https://www.ncbi.nlm.nih.gov/pubmed/31022996 http://dx.doi.org/10.15283/ijsc18055 |
Ejemplares similares
-
Small-molecule-mediated reprogramming: a silver lining for regenerative medicine
por: Kim, Yohan, et al.
Publicado: (2020) -
Transplantation of patient‐specific bile duct bioengineered with chemically reprogrammed and microtopographically differentiated cells
por: Buisson, Elina Maria, et al.
Publicado: (2021) -
Stem Cells and Regenerative Medicine: Myth or Reality of the 21th Century
por: Stoltz, J.-F., et al.
Publicado: (2015) -
MRI features of intraductal papillary mucinous neoplasm of the bile ducts, “The myth about the cyst”: A systematic review
por: Kraus, Matan, et al.
Publicado: (2023) -
Pitfalls and promises of bile duct alternatives: There is plenty of room in the regenerative surgery
por: Klabukov, Ilya D, et al.
Publicado: (2023)